10-K Filing

BIO-TECHNE CORP CIK: 842023 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001558370-23-015226`
Period End Date	20230630
Filing Date	20230823
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	tmb-20230630x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 92 Income Statement 80 Cash Flow Statement 112 Stockholders Equity 50

Balance Sheet 92 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.74M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$2.57M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$180.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$172.57M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`ShortTermInvestments`	$23.74M	USD	Point-in-time
Short-term available-for-sale investments	`ShortTermInvestments`	$74.46M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $4,738 and $2,568, respectively	`AccountsReceivableNetCurrent`	$218.47M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $4,738 and $2,568, respectively	`AccountsReceivableNetCurrent`	$194.55M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$141.12M	USD	Point-in-time
Inventories	`InventoryNet`	$171.64M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.07M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.86M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$605.56M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$621.48M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$226.20M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	156.64M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$223.24M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	157.64M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	157.64M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$98.33M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	156.64M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$65.56M	USD	Point-in-time
Goodwill	`Goodwill`	$822.10M	USD	Point-in-time
Goodwill	`Goodwill`	$843.07M	USD	Point-in-time
Goodwill	`Goodwill`	$872.74M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$615.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$534.64M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$531.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$285.30M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$46.83M	USD	Point-in-time
Total assets	`Assets`	$2.64B	USD	Point-in-time
Total assets	`Assets`	$2.29B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$33.87M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$25.68M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$36.75M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$61.95M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.88M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.89M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$23.07M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$23.41M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$12.02M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$13.24M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.20M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.93M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$3.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.41M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$176.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$128.51M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$88.98M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$98.99M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$350.00M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$243.41M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$93.77M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$58.13M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$12.24M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.92M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 157,641,914 and 156,644,212, respectively(1)	`CommonStockValue`	$1.57M	USD	Point-in-time
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 157,641,914 and 156,644,212, respectively(1)	`CommonStockValue`	$1.58M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$721.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$652.47M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.31B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.12B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-66.06M	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.70B	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.97B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-759.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.64B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.29B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$931.03M	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.11B	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.14B	USD	Annual
Stock dividend stock spilt	`StockholdersEquityNoteStockSplitConversionRatio1`	4.00	pure	Point-in-time
Cost of sales	`CostOfGoodsAndServicesSold`	$298.18M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$366.89M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$349.10M	USD	Annual
Gross margin	`GrossProfit`	$756.50M	USD	Annual
Gross margin	`GrossProfit`	$632.85M	USD	Annual
Gross margin	`GrossProfit`	$769.82M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$372.77M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$378.38M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$324.95M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$87.14M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$92.49M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$70.60M	USD	Annual
Total operating expenses	`OperatingExpenses`	$470.87M	USD	Annual
Total operating expenses	`OperatingExpenses`	$395.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$459.91M	USD	Annual
Operating income	`OperatingIncomeLoss`	$298.94M	USD	Annual
Operating income	`OperatingIncomeLoss`	$296.59M	USD	Annual
Operating income	`OperatingIncomeLoss`	$237.30M	USD	Annual
Interest expense	`InterestExpense`	$13.95M	USD	Annual
Interest expense	`InterestExpense`	$11.21M	USD	Annual
Interest expense	`InterestExpense`	$11.31M	USD	Annual
Interest income	`InvestmentIncomeNet`	$3.41M	USD	Annual
Interest income	`InvestmentIncomeNet`	$794.00K	USD	Annual
Interest income	`InvestmentIncomeNet`	$473.00K	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$47.52M	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-75.64M	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$15.31M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$4.80M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-89.12M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$39.72M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$301.39M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$338.66M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$148.18M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$38.29M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$8.59M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$53.22M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$285.44M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$139.59M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$263.10M	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-825.00K	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.95M	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$179.00K	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$140.41M	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$272.05M	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$285.26M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$4.19M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$32.95M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-32.24M	USD	Annual
Foreign currency translation reclassified to earnings with Eminence deconsolidation	`OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent`	$119.00K	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$14.26M	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$4.79M	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$7.06M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$40.01M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$9.10M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-17.98M	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-70.00K	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$103.00K	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-33.00K	USD	Annual
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-17.91M	USD	Annual
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$9.14M	USD	Annual
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$39.91M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$254.14M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$180.32M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$294.40M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.91	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.81	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.73	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.76	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.87	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.66	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	154.99M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	157.18M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	156.87M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	164.11M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	161.93M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	161.85M	shares	Annual

Cash Flow Statement 112 line items

Line Item	Tag	Value	Unit	Period
Net earnings, including noncontrolling interest	`ProfitLoss`	$285.44M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$139.59M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$263.10M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$107.24M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$101.07M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$87.75M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$400.00K	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.60M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.56M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$6.82M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-29.57M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-27.43M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$48.98M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$42.18M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$39.23M	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$5.30M	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-12.10M	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-20.40M	USD	Annual
Contingent consideration payments - operating	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.30M	USD	Annual
Contingent consideration payments - operating	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-337.00K	USD	Annual
(Gain) Loss on investment, net	`GainOnSaleOfInvestments`	$37.18M	USD	Annual
Fair value adjustment on available-for-sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$67.88M	USD	Annual
Fair value adjustment on available-for-sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-472.00K	USD	Annual
Fair value adjustment on available-for-sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-15.00M	USD	Annual
(Gain) loss on equity method investment	`IncomeLossFromEquityMethodInvestments`	$-1.14M	USD	Annual
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	$546.00K	USD	Annual
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	$18.71M	USD	Annual
Gain on sale of Eminence	`GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee`	$11.68M	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	$-1.20M	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	$2.06M	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	$75.00K	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$668.00K	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$455.00K	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-464.00K	USD	Annual
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$15.55M	USD	Annual
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$57.60M	USD	Annual
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$20.87M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$30.17M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$7.14M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$32.01M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.10M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$4.58M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.08M	USD	Annual
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.74M	USD	Annual
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$19.09M	USD	Annual
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-7.91M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$20.54M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-24.56M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$7.76M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$13.43M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$2.67M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-2.49M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$325.27M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$254.39M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$352.16M	USD	Annual
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$35.24M	USD	Annual
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$66.38M	USD	Annual
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$26.05M	USD	Annual
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$39.68M	USD	Annual
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$53.00M	USD	Annual
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$20.50M	USD	Annual
Proceeds from sale of CCXI investment	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$73.22M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$38.24M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.91M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.30M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$101.18M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$225.35M	USD	Annual
Investment in unconsolidated entity, net	`InvestmentInUnconsolidatedEntity`	$556.00K	USD	Annual
Proceeds from sale of Eminence	`ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries`	$17.82M	USD	Annual
Investment of forward purchase contract	`PaymentsForDerivativeInstrumentInvestingActivities`	$25.00M	USD	Annual
Investment in Wilson Wolf	`PaymentsToAcquireEquityMethodInvestments`	$232.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-265.65M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-96.85M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-243.52M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$50.19M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$49.62M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$50.28M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$29.81M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$65.09M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$77.16M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$19.56M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$160.95M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$43.18M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$256.00M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$619.66M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$90.00M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$175.50M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$271.50M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$525.66M	USD	Annual
Contingent consideration payments - financing	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$700.00K	USD	Annual
Taxes paid on RSUs and net share settlements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.46M	USD	Annual
Taxes paid on RSUs and net share settlements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$28.89M	USD	Annual
Taxes paid on RSUs and net share settlements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$19.34M	USD	Annual
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.46M	USD	Annual
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$788.00K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.62M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-242.85M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-62.55M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-12.09M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-3.36M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.37M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-26.52M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$52.47M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.00M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$172.57M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.57M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$172.57M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.57M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Stock dividend stock spilt	`StockholdersEquityNoteStockSplitConversionRatio1`	4.00	pure	Point-in-time
Balances (in shares)	`CommonStockSharesOutstanding`	157.64M	shares	Point-in-time
Balances (in shares)	`CommonStockSharesOutstanding`	156.64M	shares	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Reclassification of cumulative translation adjustment for Eminence to non-operating income	`OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent`	$119.00K	USD	Annual
Elimination of noncontrolling equity interest from sale of Eminence	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$613.00K	USD	Annual
Non-controlling interest in Eminence	`NoncontrollingInterestIncreaseFromBusinessCombination`	$8.98M	USD	Annual
Net earnings	`ProfitLoss`	$285.44M	USD	Annual
Net earnings	`ProfitLoss`	$139.59M	USD	Annual
Net earnings	`ProfitLoss`	$263.10M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossBeforeTranslationReclassificationNetOfTax`	$8.98M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$40.01M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$9.10M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-17.98M	USD	Annual
Share repurchases (in shares)	`StockRepurchasedDuringPeriodShares`	1.58M	shares	Annual
Share repurchases (in shares)	`StockRepurchasedDuringPeriodShares`	222,000.00	shares	Annual
Share repurchases (in shares)	`StockRepurchasedDuringPeriodShares`	480,000.00	shares	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$19.56M	USD	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$160.95M	USD	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$43.18M	USD	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2.45M	shares	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2.51M	shares	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.58M	shares	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$49.82M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$60.90M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.79M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-6.73M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-7.06M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-9.98M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$49.62M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$50.28M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$50.19M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$48.06M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$41.21M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$38.31M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$4.91M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.79M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.69M	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$915.00K	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$973.00K	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$917.00K	USD	Annual
Balances (in shares)	`CommonStockSharesOutstanding`	157.64M	shares	Point-in-time
Balances (in shares)	`CommonStockSharesOutstanding`	156.64M	shares	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.